Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. DEST.L Share Price
  4. DEST.L Share Regulatory News

Pin to quick picksDEST.L Regulatory News (DEST)

DEST.L Information
  • There is currently no data for DEST
123456
Date   Source Headline
21st Jan 20214:31 pmRNSGrant of Share Options
21st Jan 20218:28 amRNSDestiny Pharma Investor Presentation
14th Jan 202111:05 amRNSSecond Price Monitoring Extn
14th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 202111:05 amRNSSecond Price Monitoring Extn
7th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 20217:00 amRNSDestiny Pharma: Directors Dealings
6th Jan 20218:00 amRNSDestiny Pharma Appoints Stephanie Bewick as CBO
5th Jan 20217:00 amRNSPhase 2b trial of XF-73 completes recruitment
23rd Dec 20202:09 pmRNSGrant of share options
22nd Dec 20207:00 amRNSUpdate on the recently acquired NTCD-M3 programme
1st Dec 20205:23 pmRNSHolding(s) in Company
30th Nov 20202:00 pmRNSHolding(s) in Company
26th Nov 202010:50 amRNSResult of General Meeting and Total Voting Rights
25th Nov 20207:00 amRNSResult of Open Offer
9th Nov 20204:25 pmRNSFundraising and Acquisition
12th Oct 20207:00 amRNSClinical Study Patient Recruitment Update
17th Sep 20207:00 amRNSUpdate on Phase 2b clinical study of XF-73
17th Sep 20207:00 amRNSInterim results for the 6 months ended 30 Jun 2020
10th Sep 20207:00 amRNSNotice of Results
7th Sep 20204:40 pmRNSSecond Price Monitoring Extn
7th Sep 20204:35 pmRNSPrice Monitoring Extension
7th Sep 20202:06 pmRNSSecond Price Monitoring Extn
7th Sep 20202:01 pmRNSPrice Monitoring Extension
7th Sep 202011:06 amRNSSecond Price Monitoring Extn
7th Sep 202011:01 amRNSPrice Monitoring Extension
7th Sep 20209:05 amRNSSecond Price Monitoring Extn
7th Sep 20209:00 amRNSPrice Monitoring Extension
7th Sep 20207:00 amRNSCollaboration to co-develop treatment for COVID-19
11th Aug 20207:00 amRNSPositive interim safety review of XF-73 phase 2b
27th Jul 20207:00 amRNSUpdate on Phase 2b clinical study of XF-73
15th Jul 20207:00 amRNSDestiny Pharma notes launch of AMR Action Fund
19th Jun 202011:00 amRNSCancellation and Grant of Options
10th Jun 202012:30 pmRNSResult of AGM
9th Jun 20207:00 amRNSGrant awarded for Cardiff University collaboration
12th May 20203:15 pmRNSPosting of Annual Report and Notice of AGM
4th May 20207:00 amRNSIndependent review supports the potential of XF-73
29th Apr 20207:00 amRNSFinal Results
24th Apr 20207:00 amRNSNotice of Results
3rd Mar 20207:00 amRNSClinical and Business Update
20th Jan 20207:00 amRNSUpdate on the development of XF drug formulations
17th Dec 20197:00 amRNSAPSIC guidelines recommend decolonising S. aureus
2nd Dec 20197:00 amRNSDirectorate Change
2nd Dec 20197:00 amRNSDestiny to present at UK-China AMR Workshop
15th Nov 20197:30 amRNSPresentation at the Investival Showcase
6th Nov 20197:00 amRNSDestiny Pharma to present at World AMR Congress
16th Oct 20197:00 amRNSPositive phase 1 results published in journal
23rd Sep 20197:00 amRNSDirectorate Change
23rd Sep 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
12th Sep 20197:00 amRNSNotice of Results
123456

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
UMAC.US
Unusual Machines Inc
CBOE
-17.96%
DFDV
Defi Dev Corp
LSE
-12.20%
JAM
JPMorgan American
LSE
-0.49%
BKM
Bankmuscat Regs
LSE
0.00%
0HRR
Cvr Energy Ord
LSE
0.00%
Trending
IMM
Immupharma
LSE
-2.26%
CMRS
Critical Mineral Resources PLC
LSE
-4.76%
BEM
Beowulf Mining PLC
LSE
63.64%
PHE
Powerhouse Ener
LSE
4.76%
MPL
Mercantile Ports & Logistics
LSE
-16.13%